Applied DNA Sciences
Stony Brook, US · Founded 2008 · Delaware corporation · 47 employees on LinkedIn
Find your way into Applied DNA Sciences
563 people in our graph share verified history with the Applied DNA Sciences team — schools, employers, funds. One of them is your warm intro.
Jim Breyerunlockedknows Judy Murrah · together at Harvard Business School (overlapped)
×2knows the team · via Harvard Business School
×3knows the team · via Binghamton University
×2knows the team · via Stony Brook University
knows the team · via Symbol Technologies
×2knows the team · via University of Rhode Island
Founders & leadership
Applied DNA Sciences was founded in 2008 by MING-HWA BENJAMIN LIANG.
MB
MING-HWA BENJAMIN LIANGFounder
JA
James A. HaywardinCEO2005–2025James A. Hayward is Chairman of the Board, CEO and President of Applied DNA Sciences, which manufactures DNA using polymerase chain reaction technology for supply chain protection, counterfeit prevention, and applications in food, drug, vaccine, and diagnostic development.
CS
Clay ShorrockinChief Legal Officer2021–2025He has experience in biopharmaceutical manufacturing, molecular diagnostics, regulatory compliance, and technology commercialization.
BJ
Beth JantzeninControllerBeth Jantzen is CFO of Applied DNA Sciences and a CPA with more than 20 years of experience in finance leadership, capital markets, and operational transformation across biotech, diagnostics, manufacturing, and supply chain sectors. She has led capital raises, strategic restructures, and regulatory initiatives for public companies.
ML
Ming-Hwa LiangChief Technology Officer and Secretary
KG
KAROL GRAYinChief Financial Officer2013–2015
JM
Judy MurrahinBoard MemberJudy Murrah has held executive leadership positions spanning manufacturing, marketing, sales, and IT across industries including heavy manufacturing, technology, and biotech, with experience in both public companies and nonprofits.
Board
JB
John Bitzer, IIIBoard director
JD
Joseph D. CeccoliBoard director
EM
Elizabeth M. Schmalz ShaheenBoard director
SR
Sanford R. SimonBoard director
YS
Yacov ShamashBoard director
Reported raises · per SEC filings
Form D private placements$75M disclosed across 11 of 13 rounds · 2014–2026
▶$2.5MraisedJun 2026 · 1 investors · OtherRule 506(b)
▶$2.5MraisedJun 2026 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Joshua KrugerDirector
- Clay D. ShorrockExecutive Officer
- Judith MurrahDirector
- James HaftDirector
- Robert B. CatellDirector
- Yacov A. ShamashDirector
- Beth M. JantzenExecutive Officer
- Joseph D. CeccoliDirector
- Offering amount
- $5M
- Amount sold
- $2.5M
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$58MraisedOct 2025 · 33 investors · BiotechnologyRule 506(b)
▶$58MraisedOct 2025 · 33 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert B. CatellDirector
- Clay ShorrockExecutive Officer
- Beth JantzenExecutive Officer
- Joseph D. CeccoliDirector
- Judith MurrahExecutive Officer, Director
- Yacov A. ShamashDirector
- Elizabeth M. Schmalz ShaheenDirector
- Offering amount
- $58M
- Amount sold
- $58M
- Sales commissions
- $361.7K
- Proceeds to insiders
- $725K
- Placement agents
- Lucid Capital Markets, LLC
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13.3MofferedNov 2024 · 8 investors · BiotechnologyRule 506(b)
▶$13.3MofferedNov 2024 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph D. CeccoliDirector
- Elizabeth M. Schmalz ShaheenDirector
- Sanford R. SimonDirector
- James A. HaywardExecutive Officer, Director
- Yacov ShamashDirector
- Clay ShorrockExecutive Officer
- Beth JantzenExecutive Officer
- Robert B. CatellDirector
- Judith MurrahExecutive Officer
- Offering amount
- $13.3M
- Sales commissions
- $490K
- Placement agents
- Craig-Hallum Capital Group LLC
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.9MofferedFeb 2024 · 3 investors · BiotechnologyRule 506(b)
▶$6.9MofferedFeb 2024 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Joseph D. CeccoliDirector
- Clay ShorrockExecutive Officer
- Sanford R. SimonDirector
- Robert B. CatellDirector
- James A. HaywardExecutive Officer, Director
- Yacov A. ShamashDirector
- Beth JantzenExecutive Officer
- Elizabeth M. Schmalz ShaheenDirector
- Judith MurrahExecutive Officer
- Offering amount
- $6.9M
- Sales commissions
- $273.4K
- Placement agents
- Maxim Group LLC
- First sale
- Feb 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.2MraisedOct 2020 · 2 investors · BiotechnologyRule 506(b)
▶$1.2MraisedOct 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James A. HaywardExecutive Officer, Director
- Beth JantzenExecutive Officer
- Judith MurrahExecutive Officer
- John Bitzer, IIIDirector
- Elizabeth M. Schmalz FergusonDirector
- Joseph D. CeccoliDirector
- Scott AnchinDirector
- Sanford R. SimonDirector
- Yacov A. ShamashDirector
- Robert B. CatellDirector
- Offering amount
- $3.7M
- Amount sold
- $1.2M
- First sale
- Oct 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$418KraisedAug 2019 · 5 investors · BiotechnologyRule 506(b)
▶$418KraisedAug 2019 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Elizabeth M. Schmalz FergusonDirector
- Yacov A. ShamashDirector
- Sanford R. SimonDirector
- Charles S. RyanDirector
- Robert B. CatellDirector
- James A. HaywardExecutive Officer, Director
- Beth JantzenExecutive Officer
- Judith MurrahExecutive Officer
- John Bitzer, IIIDirector
- Joseph D. CeccoliDirector
- Offering amount
- $418K
- Amount sold
- $418K
- First sale
- Aug 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedJul 2019 · 1 investors · BiotechnologyRule 506(b)
▶$1.5MraisedJul 2019 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James A. HaywardExecutive Officer, Director
- Beth JantzenExecutive Officer
- Judith MurrahExecutive Officer
- John Bitzer, IIIDirector
- Robert B. CatellDirector
- Joseph D. CeccoliDirector
- Charles S. RyanDirector
- Sanford R. SimonDirector
- Yacov A. ShamashDirector
- Elizabeth M. Schmalz FergusonDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Jul 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedSep 2018 · 11 investors · BiotechnologyRule 506(b)
▶$1.6MraisedSep 2018 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Judith MurrahExecutive Officer
- Beth JantzenExecutive Officer
- James A. HaywardExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $1.6M
- First sale
- Aug 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Applied DNA Sciences?
- Applied DNA Sciences was founded by MING-HWA BENJAMIN LIANG in 2008.
- How much funding has Applied DNA Sciences raised?
- Applied DNA Sciences has disclosed $75M raised across 11 of its 13 known rounds.
- Where is Applied DNA Sciences headquartered?
- Applied DNA Sciences is headquartered in Stony Brook, US.